Value-based pricing and strategy
Develop pricing strategies that reflect the true value of your asset and gain insights to help you understand and quantify investment trade-offs.
Our expertise supports your pricing negations and includes:
- Comprehensive assessments of the pricing and reimbursement landscape for your product through critical analysis of existing HTA and reimbursement decisions
- Tailored research based on different endpoint scenarios to improve understanding of payer evidence requirements and support your value-based pricing and reimbursement strategy
- Primary research through international advisory boards and interviews with payers and clinicians to understand real-world issues and decision-drivers.
It is critical to understand the scale and potential impact of high-cost and/or combination treatments coming to market, which can force significant changes in pricing and reimbursement policies; we can help you develop innovative pricing and contracting strategies to support the best outcomes for your asset.
Our consulting solutions include:
- Evaluation of economically justifiable price
- Payer pricing research
- Innovative pricing and contracting strategy
- Lifecycle management pricing strategy
These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.
Request a call
